Found 13 matching trials
IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4 NA The primary aim of the study is to determine if provision of a patient info...
Show More Location
European Institute of Oncology
Learn More & Join Trial
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial PHASE3 This phase III trial compares standard of care hormone therapy plus ribocic...
Show More Location
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Learn More & Join Trial
(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer N/A This study is a multi-center BCCA study that evaluates the impact of the On...
Show More Location
BC Cancer Agency - Vancouver Centre
Learn More & Join Trial
Endocrine Therapy Base on 21-gene RS N/A Among patients aged ≤50 years with hormone receptor-positive, HER2-negative...
Show More Location
Multiple Locations
Learn More & Join Trial
Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study N/A The study aims to evaluate the distribution of the Oncotype DX RS® genomic ...
Show More Location
IRCCS Ospedale San Raffaele
Learn More & Join Trial
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) PHASE3 This randomized phase III trial studies the best individual therapy for wom...
Show More Status
Active Not Recruiting
Location
Northeast Alabama Regional Medical Center
Learn More & Join Trial
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer PHASE2 This study aims to utilize a novel biomarker-driven approach to guide neoad...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients NA Primary objective:
Determine the impact of the Oncotype DX Recurrence Scor...
Show More Learn More & Join Trial
Developing a Diagnostic Tool to Predict Response to Chemotherapy N/A Every year nearly 62,000 people are diagnosed with breast cancer in the UK....
Show More Location
Nottingham University Hospitals NHS Trust
Learn More & Join Trial
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer PHASE2 This study will look at the safety and effectiveness of the combination of ...
Show More Location
Breast Cancer Care Specialist
Learn More & Join Trial